Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 5
Research Paper
Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial
Michael Horna Pediatric Office, Schönau Am Königssee, Germany
https://orcid.org/0000-0002-4699-5969View further author information
https://orcid.org/0000-0002-4699-5969View further author information, , , Kurt Dobbelaerec HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-5426-2626View further author information
https://orcid.org/0000-0002-5426-2626View further author information & Dorota Borysc HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-9704-8462View further author information
https://orcid.org/0000-0001-9704-8462View further author information